![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/397 | |
A61K 31/137 | |||
A61K 45/06 | |||
A61P 3/10 | |||
A61P 3/04 | |||
A61P 25/28 | |||
A61P 25/24 | |||
A61P 43/00 |
(11) | Number of the document | 2142184 |
(13) | Kind of document | T |
(96) | European patent application number | 08749978.6 |
Date of filing the European patent application | 2008-05-01 | |
(97) | Date of publication of the European application | 2010-01-13 |
(45) | Date of publication and mention of the grant of the patent | 2018-10-24 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2008/055405 |
Date | 2008-05-01 |
(87) | Number | WO 2008/135522 |
Date | 2008-11-13 |
(30) | Number | Date | Country code |
915985 P | 2007-05-04 | US |
(72) |
BARDE, Yves-Alain, CH
BILBE, Graeme, CH
DEOGRACIAS, Ruben, CH
KUHN, Rainer, R., CH
MATSUMOTO, Tomoya, CH
MIR, Anis, Khusro, FR
SCHUBART, Anna, Svenja, CH
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | USE OF S1P RECEPTOR MODULATOR |
USE OF S1P RECEPTOR MODULATOR |